Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nutriband Inc NTRB

Healthcare
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. The Company's development pipeline includes AVERSA Buprenorphine and AVERSA Methylphenidate. The Company is also developing a portfolio of transdermal... see more

Recent & Breaking News (NDAQ:NTRB)

Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee

Accesswire March 2, 2023

Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register

Accesswire February 15, 2023

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference

Accesswire January 24, 2023

Nutriband Inc. Commences Trading on Upstream Under NTRB

Accesswire January 5, 2023

Nutriband Inc. Will Be the First Company to Dual List on Upstream

Accesswire December 30, 2022

Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023

Accesswire December 29, 2022

Nutriband Approved for Dual Listing on Upstream

Accesswire December 14, 2022

Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

Accesswire December 14, 2022

Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3

Accesswire December 5, 2022

Nutriband Inc to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022

Accesswire December 2, 2022

Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA(TM) Abuse Deterrent Transdermal Technology Patent

Accesswire December 1, 2022

Nutriband Supports Newly Published CDC Opioid Prescribing Guidelines

Accesswire November 8, 2022

Nutriband Inc. to Manufacture Fleur Marché-branded Wellness Patches Under Exclusive Agreement

Accesswire October 27, 2022

Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheumatology Conference

Accesswire October 26, 2022

Nutriband Inc. Invited to Present at the 2023 Transdermal and Microneedle Conference in London on January 23 and 24

Accesswire October 17, 2022

Nutriband With Kindeva Drug Delivery Demonstrate Enhanced Abuse-Deterrent Characteristics for AVERSA(TM) Fentanyl

Accesswire October 4, 2022

Nutriband Inc. Announces Application for Dual Listing on Upstream

Accesswire October 3, 2022

Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

Accesswire September 15, 2022

Nutriband Inc. Reports Revenue Up 113% YoY in Q2

Accesswire September 8, 2022

Nutriband Inc. Provides Update on Seven-for-Six Forward Stock Split

Accesswire August 16, 2022